Abiopharma

News list

Altimmune Inc (ALT)

Business News
June 26, 2025, 11:01 UTC

Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH

Full text

Register to leave comments
There are no comments here yet...